Key Patent Issued on Qantu's QT-0101 Adjuvant
25 févr. 2019 05h00 HE
|
QANTU Therapeutics, Inc.
LEWISVILLE, Texas, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Qantu Therapeutics, Inc. announces the issuance of United States patent 10,195,257 titled “Vaccine Formulations Comprising Quillaja...
Qantu Publishes Study Analyzing the Situation of Alzheimer's Disease Vaccines Development
20 avr. 2016 09h00 HE
|
QANTU Therapeutics, Inc.
LEWISVILLE, TX--(Marketwired - April 20, 2016) - Qantu Therapeutics, Inc. announces the publication of the article "A retrospective analysis of the Alzheimer's disease vaccine progress The...